John F. Ginascol - Oct 27, 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EXECUTIVE VICE PRESIDENT
Signature
/s/ John F. Ginascol by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Oct 27, 2021
Transactions value $
-$1,642,787
Form type
4
Date filed
10/27/2021, 06:45 PM
Previous filing
Jun 7, 2021
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $2.15M +45.7K +46.86% $47.00 143K Oct 27, 2021 Direct
transaction ABT Common shares without par value Tax liability -$3.79M -29.6K -20.65% $128.13 114K Oct 27, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -45.7K -100% $0.00* 0 Oct 27, 2021 Common Shares 45.7K $47.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.